Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Published:2010-10-28 Issue:18 Volume:363 Page:1693-1703
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Kwak Eunice L.,Bang Yung-Jue,Camidge D. Ross,Shaw Alice T.,Solomon Benjamin,Maki Robert G.,Ou Sai-Hong I.,Dezube Bruce J.,Jänne Pasi A.,Costa Daniel B.,Varella-Garcia Marileila,Kim Woo-Ho,Lynch Thomas J.,Fidias Panos,Stubbs Hannah,Engelman Jeffrey A.,Sequist Lecia V.,Tan WeiWei,Gandhi Leena,Mino-Kenudson Mari,Wei Greg C.,Shreeve S. Martin,Ratain Mark J.,Settleman Jeffrey,Christensen James G.,Haber Daniel A.,Wilner Keith,Salgia Ravi,Shapiro Geoffrey I.,Clark Jeffrey W.,Iafrate A. John

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1006448

Cited by 3923 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bilateral chronic photopsias in a woman;Clinical Cases in Medical Retina;2025

2. Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience;The Journal of Liquid Biopsy;2024-12

3. Macrocyclic-based strategy in drug design: From lab to the clinic;European Journal of Medicinal Chemistry;2024-11

4. Epinephrine, Pregabalin, and Crizotinib as Three Medicines with Polish Implications over Three Last Centuries and in View of Three Different Drug Discovery Approaches;Biomedicines;2024-09-04

5. Clinical potential of SKP2 as diagnostic marker and therapeutic target in small cell lung cancer;Respiratory Investigation;2024-09